News
AlzeCure’s Alzheimer’s candidate shows promise
AlzeCure Pharma – a company that develops a portfolio of small molecule candidate drugs for diseases affecting the central nervous system – has announced an abstract regarding its drug candidate NeuroRestore ACD856.